UNSPSC 51293101: Adafenoxate

This classification denotes an antidepressant agent with the molecular formula C20H26ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B8VQU4C05J, chemically known as 2-(1-tricyclo(3.3.1.1(3,7))decylamino)ethyl (4-chlorphenoxy)acetat but generally known as adafenoxate, which bears US NIH Compound Identifier 64517. European Medicines Agency schedules Adafenoxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05259MIG.

UNSPSC 51293101 Adafenoxate is a Commodity code, but the recent state and local solicitation activity under this code does not align with the pharmaceutical product specified by the code name. Seminole County, Florida, the sole recent opportunity in the dataset, issued IFB 60459723LAS in June 2026 to procure naloxone and drug deactivation systems for community health support — a scope that diverges materially from adafenoxate, a pharmaceutical compound used in different clinical contexts. The mismatch suggests either a coding error in the county's procurement system or that the code is not actively used for state and local healthcare product procurement in the way its taxonomy designation implies.

The single identified opportunity — Seminole County's purchase of 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding — shows quarterly delivery requirements to a specific county health facility, with shipping included in vendor pricing. The contract carries a two-year initial term with a one-year renewal option, E-Verify compliance, and drug-free workplace certification as standard conditions. No explicit set-aside designations appear in the procurement. With only one recent opportunity in the dataset and no broader geographic or multi-jurisdictional activity evident, the code shows limited measurable state and local procurement velocity. Vendors should verify whether this code remains in active use by other jurisdictions or whether naloxone and related harm-reduction products are typically procured under alternative UNSPSC classifications by most state and local health agencies.